The novel treatment of this peptide represents a major development in the care of diabetes mellitus type 2. Different to existing therapies, tirzepatide targets dual pathways – GLP-1 and GIP – providing improved https://tirzepatidepeptide306260.ja-blog.com/42334514/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment